Dr. Drucker received his M.D. from the University of Toronto in 1980, and is currently Professor of Medicine, the Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology at the University of Toronto and a Senior Scientist at the Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital. His laboratory studies the molecular biology and physiology of gut hormones with a focus on the glucagon-like peptides. Dr. Drucker's scientific studies identified multiple novel mechanisms of hormone action, enabling development of new drug classes for diabetes, obesity and intestinal failure. His discoveries have been recognized by numerous learned societies with awards and elections.